Cite
HARVARD Citation
Sanoff, H. et al. (2018). Multicenter, randomized, double‐blind phase 2 trial of FOLFIRI with regorafenib or placebo as second‐line therapy for metastatic colorectal cancer. Cancer. 124 (15), pp. 3118-3126. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sanoff, H. et al. (2018). Multicenter, randomized, double‐blind phase 2 trial of FOLFIRI with regorafenib or placebo as second‐line therapy for metastatic colorectal cancer. Cancer. 124 (15), pp. 3118-3126. [Online].